AXDX - Wutah pendapatan YoY sajrone 12 wulan kepungkur Accelerate Diagnostics Inc

Tandha merek Accelerate Diagnostics (AXDX)

Comparable year-over-year sales growth over 12 months demonstrates the effect of implementing hospital rapid diagnostic systems, which create sustainable B2B dependency. Revenues are based on the sale of equipment and consumable cartridges. Despite its leadership in sepsis detection, expansion requires significant investment. The value of -8.40 reflects the latest metric value, allowing for an assessment of the real dynamics of Accelerate Diagnostics (AXDX) operational inflows.

Wutah dodolan YoY sajrone rolas wulan kepungkur Accelerate Diagnostics Inc. (AXDX): kanggo periode 11.02.2024 - 20.02.2024

Ringkesan rincian data analitis Accelerate Diagnostics, Inc. (AXDX)

- kuotasi saiki lan rata-rata prakiraan nilai:
Kutipan saham Accelerate Diagnostics, Inc|AXDX - Prakiraan konsensus analis
- statistik kapitalisasi pasar:
Biji pasar Accelerate Diagnostics, Inc.|AXDX - Nilai Perusahaan
- data nilai buku modal saham:
Nilai Aset Bersih saben Saham Accelerate Diagnostics|AXDX - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku acceleratediagnostics.com|AXDX - Total Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Accelerate Diagnostics|AXDX - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Accelerate Diagnostics, Inc.|AXDX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Accelerate Diagnostics, Inc|AXDX - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Accelerate Diagnostics|Likuiditas darurat acceleratediagnostics.com
- rincian bathi lan kelipatan pasar:
AXDX - Penghasilan resik|Penghasilan resik sing dikarepake Accelerate Diagnostics|AXDX - Pangali P/E|Rasio rega marang bathi mangsa ngarep Accelerate Diagnostics|AXDX - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Accelerate Diagnostics, Inc.|AXDX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Accelerate Diagnostics|AXDX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku acceleratediagnostics.com|AXDX - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Accelerate Diagnostics
- data dodolan lan asil:
AXDX - Pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Accelerate Diagnostics Inc|AXDX - Rasio rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Accelerate Diagnostics, Inc|AXDX - Wutah pendapatan YoY sajrone 12 wulan kepungkur
Ringkesan analitik perusahaan:AXDX (Accelerate Diagnostics)
Produk asil prodhuksi acceleratediagnostics.com

This indicator calculates the percentage change in total revenue over the last twelve months relative to the same period last year, neutralizing seasonal fluctuations and revealing the true vector of business expansion. For Accelerate Diagnostics (AXDX), the TTM revenue growth trajectory compared to last year confirms the monetization of high laboratory confidence in the accuracy of its diagnostic systems, transforming the brand's reputational stability into real financial scale.

Analisis pesaing Accelerate Diagnostics

Agilent Corp (A) - Wutah pendapatan taun lumaku|DGX - Wutah dodolan YoY sajrone rolas wulan kepungkur|ILMN: Wutah dodolan YoY sajrone rolas wulan kepungkur|EXAS: Wutah dodolan YoY (TTM)|RVTY (Revvity) - Wutah dodolan YoY sajrone rolas wulan kepungkur|BIO (Bio-Rad Laboratories, Inc.) - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Anbio Biotechnology NNNN|Wutah pendapatan YoY sajrone 12 wulan kepungkur SHC (Sotera Health Company)|Wutah dodolan YoY sajrone rolas wulan kepungkur QDEL (quidel.com)|Wutah dodolan YoY (TTM) OPK (opko.com)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CDNA|MRVI: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur FLGT (Fulgent Corp)|LAB: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku cytekbio.com (CTKB)|OSUR (OraSure Corp) - Wutah dodolan YoY (TTM)|Exagen (XGN) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Wutah dodolan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Prenetics PRE|Insight Molecular (IMDX) - Wutah pendapatan taun lumaku|Trinity Biotech Corp - Wutah dodolan YoY (TTM)|Wutah pendapatan taunan sajrone rolas wulan kepungkur ProPhase PRPH|AIMD: Wutah dodolan YoY (TTM)|CODX - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Heart Test Laboratories, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur BMRA|Wutah dodolan YoY (TTM) CDIO|Onconetix - Wutah dodolan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur viraxbiolabs.com VRAX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Bluejay (BJDX)|AWH: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Centogene NV (CNTG)|ENZ (Enzo Biochem) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|fresh2.co (FRES) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur Genetic Technologies Limited|Wutah pendapatan taun lumaku 23andMe Inc. ME|Wutah dodolan YoY sajrone rolas wulan kepungkur Psychemedics (PMD)